Tufts Clinical and Translation Science Institute (UL1)

塔夫茨临床与翻译科学研究所 (UL1)

• 批准号: 8089758
• 负责人: Harry P. Selker
• 金额: $ 44.77万
• 依托单位: TUFTS UNIVERSITY BOSTON
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-07-08 至 2011-07-07
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8089758
• 关键词: Aging; Arts; Biomedical Engineering; Biometry; Clinical; Clinical Research; Clinical Trials; Dental Care; Development; Distance Learning; Doctor of Philosophy; Engineering; Epidemiology; Evidence Based Medicine; Faculty; Generations; Head; Health Policy; Home environment; Hospitals; Human; Information Systems; Institutes; Interdisciplinary Study; International; Joints; K-Series Research Career Programs; Massachusetts; Medical Informatics; Medical center; Medicine; Mentors; Minority Groups; New England; Nutritional Study; Outcomes and Health Services Research; Process; Reporting; Research Methodology; Research Support; Resources; SECTM1 gene; Schools; Science; Students; Training; Translational Research; Translations; Underrepresented Minority; Universities; Veterinary Medicine; base; bench to bedside; drug development; innovation; interest; novel; nutrition; pre-doctoral; programs

Leveraging Tufts University's excellent resources, traditions of multidisciplinary collaboration, generation of novel research methods, and academic innovation, including the first MS/PhD Clinical Research (CR) Program in a graduate school of biomedical sciences, we will establish the Tufts Clinical and Translational Science Institute (CTSI). This will unite eight Tufts Schools (Arts & Sciences, Citizenship and Public Service, Dental Medicine, Engineering, Graduate Biomedical Sciences, Medicine, Nutrition, and Veterinary Medicine), eight affiliated hospitals, the Tufts Center for the Study of Drug Development, the USDA Human Nutrition Research Center on Aging at Tufts, and the Tufts-New England Medical Center (Tufts-NEMC) Institute for Clinical Research and Health Policy Studies. This will: 1) Create a new home for clinical and translational clinical research (CTR), a cross-University, cross-affiliate Tufts CTSI, headed by an international leader in CTR who will report to the University Provost; 2) Create eight research resource Components suggested by the CTSA RFA, plus four based on special Tufts strengths; 3) Enhance and expand the "CR Portal" at Tufts- NEMC into a Tufts-wide "CTSI Portal" that provides coordinated and mentored University- and affiliate-wide access to CTSI Components and other resources; 4) Create activities, processes, and new information systems that will support and promote collaborative cross-disciplinary full-spectrum translational research; and 5) Enhance our MS/PhD CR Program by a) adding to the existing four Concentrations (Clinical Investigation, Epidemiology/Biostatistics, Health Services and Outcomes Research, and Medical Informatics), Concentrations in Bench-to-Bedside Translational Research and in Evidence-Based Medicine; b) developing distance learning to extend the Program to fellows, K12 scholars, and other faculty at Tufts affiliates across Massachusetts; c) creating the joint Pfizer Tufts Career Development Awards; d) preparing predoctoral tracks for Tufts MD, DMD, and DVM students to also get a CR MS or PhD; e) developing joint tracks for students to get an MS in Nutrition or in Biomedical Engineering with a PhD in CR; and f) developing a program to generate interest in CTR among students from underrepresented minority groups. In all aspects of training, research support, and organizational development, the Tufts CTSI will support and instill the culture of cooperative interdisciplinary research, a home without walls, for CTR Tufts-wide.

利用塔夫茨大学的优秀资源，多学科合作的传统， 新颖的研究方法和学术创新，包括第一个MS/PhD临床研究（CR） 计划在生物医学科学的研究生院，我们将建立塔夫茨临床和翻译 科学研究所（CTSI）。这将联合八个塔夫茨学校（艺术与科学，公民和公共服务， 牙科医学、工程学、研究生生物医学科学、医学、营养学和兽医学）， 八家附属医院，塔夫茨药物开发研究中心，美国农业部人类营养研究所 塔夫茨-新英格兰医学中心（Tufts-NEMC）研究所 临床研究和卫生政策研究。这将：1）为临床和翻译创造一个新的家园 临床研究（CTR），一个跨大学，跨附属塔夫茨CTSI，由一个国际领导者领导， CTR将向大学教务长报告; 2）创建八个研究资源组件， CTSA RFA，加上四个基于特殊塔夫茨优势; 3）加强和扩大塔夫茨的“CR门户”- NEMC成为塔夫茨范围内的“CTSI门户网站”，提供协调和指导的大学和附属机构范围内 访问CTSI组件和其他资源; 4）创建活动、流程和新信息 支持和促进跨学科全谱转化研究的系统; 和5）通过a）增加现有的四个浓度（临床）来加强我们的MS/PhD CR计划 调查，流行病学/生物统计学，卫生服务和成果研究，以及医疗 信息学），集中在实验室到床边的转化研究和循证医学; B）发展远程学习，将该计划扩展到研究员，K12学者和塔夫茨大学的其他教师 在马萨诸塞州的分支机构; c）创建联合辉瑞塔夫茨职业发展奖; d）准备 塔夫茨MD，DMD和DVM学生的博士预科课程也可以获得CR MS或博士学位; e）开发联合 学生获得营养学硕士学位或生物医学工程博士学位的途径;以及f） 制定一个计划，以产生对来自代表性不足的少数群体的学生CTR的兴趣。 在培训，研究支持和组织发展的各个方面，塔夫茨CTSI将支持 并灌输跨学科合作研究的文化，一个没有围墙的家，为CTR塔夫茨范围内。